Navigation Links
Lipitor Lawsuits Continue to Mount, as Bernstein Liebhard LLP Notes Filing of New Claim Alleging an Association Between Lipitor and Diabetes

(PRWEB) November 13, 2013

Lipitor lawsuits ( continue to mount in courts around the country, as Bernstein Liebhard LLP notes the filing of a new claim in West Virginia Federal Court on behalf of a woman who allegedly developed new-onset Type 2 diabetes due to her use of the cholesterol –lowering drug. According to court documents filed on October 28th in U.S. District Court, Northern District of West Virginia, the Plaintiff began taking Lipitor in 2005 and was diagnosed with diabetes in 2009. Like other lawsuits involving Lipitor and diabetes, the complaint alleges that Pfizer, Inc. failed to provide adequate warnings regarding the risks associated with the statin medication. (3:2013cv00154)

“This case is of great interest to our Firm, as we continue to hear from Lipitor patients who allegedly had similar experiences with this drug. The complaint also echoes allegations put forth in scores of other recent Lipitor lawsuit filings,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free legal consultations to alleged victims of Lipitor and diabetes.

Lipitor Lawsuits
According to a petition filed with the U.S. Judicial Panel on Multidistrict Litigation (JPML) in October, more than 100 Lipitor lawsuits involving diabetes allegations are now pending in courts around the country. Plaintiffs are seeking the consolidation of all federally-filed Lipitor lawsuits in a multidistrict litigation, and transfer of the cases to a single judge in U.S. District Court, District of South Carolina. According to their petition, a number of Lipitor claims are already pending in the district, and are being informally handled in a coordinated manner. (In re Lipitor (Atorvastatin) Litigation, MDL No. 2502 (JPML))

According to court documents, the October petition marked plaintiffs’ second request for the establishment of a multidistrict litigation for Lipitor lawsuits. Their first petition, which was filed in April, was rejected by the JPML on the grounds that there were too few filings to warrant a consolidated proceeding. However, at that time, just around a dozen Lipitor lawsuits had been filed in federal courts.

Court records filed in U.S. District Court, Southern District of Illinois also indicate that a number of similar lawsuits involving Lipitor and diabetes have also been consolidated in that jurisdiction for the purposes of discovery and other pretrial proceedings. (Hines v.Pfizer Inc., No. 13-404, S.D. Ill.)

In January 2012, a study that appeared in JAMA: Internal Medicine reported that post-menopausal women treated with drugs like Lipitor were at increased risk of developing new-onset Type 2 diabetes.* A month later, the U.S. Food & Drug Administration (FDA) ordered Pfizer, Inc. to add new warnings to the Lipitor label regarding its possible association with an increased risk of diabetes.

In May 2013, the British Medical Journal also reported an association between Lipitor and diabetes, finding that patients who took the drug had a 22 percent increased risk of new-onset diabetes.**

Alleged victims of Lipitor and diabetes may be eligible for compensation for medical bills, lost wages, pain and suffering and more. Learn more about Lipitor lawsuits at Bernstein Liebhard LLP’s website. To arrange for a free legal review, please call 800-511-5092.

*, JAMA Internal Medicine, January 2012
**, BMJ, May 2013

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 11 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Lipitor Diabetes Lawsuit Filed by South Carolina Woman Who Developed Type 2 Diabetes Allegedly Due to Lipitor Use, Alonso Krangle Investigating
2. Lipitor Lawsuit News: Rottenstein Law Group Comments on FDA Approval of New Drug With Lipitor Compound
3. Lipitor Lawsuit News: US Spending on Drugs Fell For First Time in 2012, Notes Rottenstein Law Group LLP
4. Lipitor Lawsuit News: Rottenstein Law Group LLP Responds to Reports of Lipitor Giveaway
5. Lipitor News: Rottenstein Law Group LLP Comments on Boomers’ Favorite Drug
6. National Law Firm Baron and Budd Responds to Disproportionate Harm Brought to Women Using Lipitor, According to Study
7. National Law Firm Baron and Budd Helping Women with Alleged Injuries from Lipitor Use Understand the Lipitor Lawsuit
8. Lipitor Lawsuit Website Launched by Bernstein Liebhard LLP to Provide Information to the Public Regarding Lipitor Side Effects, Ongoing Litigation
9. Lipitor Lawsuit News: Judicial Panel Denies Consolidation of Federal Cases, Rottenstein Law Group LLP Reports
10. Warning of Statin Drug Lipitor’s Risk of Type 2 Diabetes Came Too Late Say Patients Filing Lipitor Lawsuits
11. Dozens of Lipitor Lawsuits Involving Diabetes Allegations Moved to Federal Court, Bernstein Liebhard LLP Reports
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... Consistent with the ... 2016 Building Better Radiology Marketing Programs meeting will showcase some of ... 6, 2016, at Caesars Palace in Las Vegas with a pre-conference session on ...
(Date:11/27/2015)... ... November 27, 2015 , ... The moment ... itself for not only fulfilling the needs of advisers and clients but going ... price and providing top-tier customer service. However, there's always room for improvement, which ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... successful and prominent nonprofit healthcare organizations in the country. They have overseen financial ... organizations, and helped advance the healthcare industry as a whole through their advocacy ...
(Date:11/27/2015)... ... , ... Indosoft Inc., developer and distributor of the world-class ... (Long Term Support) into its Q-Suite 5.10 product line. , Making the change ... version of Asterisk that will receive not only security fixes, but feature and ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... eReferral system for diagnostic imaging in the Waterloo region. Using the Ocean Platform, ... Medicine tests directly from their electronic medical record (EMR) without the need for ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 26, 2015 --> ... SyMRI to find optimal contrast weighting of MRI for ... has signed a research agreement with SyntheticMR in order to ... SyMRI, it is possible to generate multiple contrast images from ... patient has left, thus making it possible to both fine ...
(Date:11/26/2015)... 3D bioprinting market is expected to reach ... by Grand View Research Inc. Rising prevalence of chronic diseases ... is expected to boost the market growth, as 3D bioprinting ... --> 3D bioprinting market is expected to reach ... by Grand View Research Inc. Rising prevalence of chronic diseases ...
(Date:11/26/2015)... , November 26, 2015 ... addition of the "2016 Future Horizons ... of Abuse Testing Market: Supplier Shares, Country ... report to their offering. --> ... the "2016 Future Horizons and Growth ...
Breaking Medicine Technology: